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The national and subnational prevalence of 
cataract and cataract blindness in China:  
a systematic review and meta-analysis
Background Cataract is the second leading cause of visual impairment and the first of 
blindness globally. However, for the most populous country, China, much remains to be 
understood about the scale of cataract and cataract blindness. We aimed to investigate 
the prevalence of cataract and cataract blindness in China at both the national and sub-
national levels, with projections till 2050.
Methods In this systematic review and meta-analysis, China National Knowledge In-
frastructure (CNKI), Wanfang, Chinese Biomedicine Literature Database (CBM-
SinoMed), PubMed, Embase, and Medline were searched using a comprehensive search 
strategy to identify all relevant articles on the prevalence of cataract or cataract blind-
ness in Chinese population published from January 1990 onwards. We fitted a multi-
level mixed-effects meta-regression model to estimate the prevalence of cataract, and a 
random-effects meta-analysis model to pool the overall prevalence of cataract blindness. 
The United Nations Population Division (UNPD) data were used to estimate and proj-
ect the number of people with cataract and cataract blindness from 1990 to 2050. Ac-
cording to different demographic and geographic features in the six geographic regions 
in China, the national numbers of people with cataract in the years 2000 and 2010 
were distributed to each region.
Results In males, the prevalence of any cataract (including post-surgical cases) ranged 
from 6.71% (95% CI = 5.06-8.83) in people aged 45-49 years to 73.01% (95% CI = 65.78-
79.2) in elderly aged 85-89 years. In females, the prevalence of any cataract increased 
from 8.39% (95% CI = 6.36-10.98) in individuals aged 45-49 years to 77.51% (95% 
CI = 71.00-82.90) in those aged 85-89 years. For age-related cataract (ARC, including 
post-surgical cases), in males, the prevalence rates ranged from 3.23% (95% CI = 1.51-
6.80) in adults aged 45-49 years to 65.78% (95% CI = 46.72-80.82) in those aged 85-
89 years. The prevalence of ARC in females was 4.72% (95% CI = 2.22-9.76) in the 45-
49 years age group and 74.03% (95% CI = 56.53-86.21) in the 85–89 years age group. 
The pooled prevalence rate of cataract blindness (including post-surgical cases) by best 
corrected visual acuity (BCVA)<0.05 among middle-aged and older Chinese was 2.30% 
(95% CI = 1.72-3.07), and those of cataract blindness by BCVA<0.10 and cataract blind-
ness by presenting visual acuity (PVA)<0.10 were 2.56% (95% CI = 1.94-3.38) and 
4.51% (95% CI = 3.53-5.75) respectively. In people aged 45-89 years, the number of any 
cataract cases was 50.75 million (95% CI = 42.17-60.37) in 1990 and 111.74 million 
(95% CI = 92.94-132.84) in 2015, and that of ARC rose from 35.77 million (95% 
CI = 19.81-59.55) in 1990 to 79.04 million (95% CI = 44.14-130.85) in 2015. By 2050, 
it is projected that the number of people (45-89 years of age) affected by any cataract 
will be 240.83 million (95% CI = 206.07-277.35), and that of those with ARC will be 
187.26 million (95% CI = 113.17-281.23). During 2000 and 2010, South Central Chi-
na consistently owed the most cases of any cataract, whereas Northwest China the least.
Conclusions The prevalence of cataract and cataract blindness in China was unmasked. 
In the coming decades, cataract and cataract blindness will continue to be a leading pub-
lic-health issue in China due to the ageing population. Future work should be priori-
tized to the promotion of high-quality epidemiological studies on cataract.
Electronic supplementary material: 
The online version of this article contains supplementary material.
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Cataract, defined as any opacity of the crystalline lens in the eye that affects clear vision, is a common 
condition in later life [1-3]. If left untreated, cataract can eventually progress to severe visual impairment 
or even blindness [4,5]. Compared to the general population, people with cataract are more likely to have 
substantially reduced vision-related quality of life and increased risk of comorbidity and mortality [3,6-
10]. Surgery is cost-effective and successful in restoring cataract-related vision loss [11-13]. However, in 
many resource-deprived areas, especially remote and poor areas in developing countries, barriers in ac-
cess to appropriate preventative eye care and surgical treatments still exist, presenting an enormous prob-
lem to the society in terms of social and economic burden [14-17]. Based on aetiology, cataract can be 
broadly classified as age-related, congenital, traumatic, secondary and drug-induced, etc., with age-relat-
ed cataract (ARC) being the predominant subtype [1,3].
Despite the fact that cataract can be easily, safely and cost-efficiently treated with a standard procedure, 
cataract still remains the second leading cause of visual impairment and the first of blindness globally 
[3,5,18]. According to the latest estimates in 2010, 94 million people were visually impaired and 20 mil-
lion were blind because of cataract, accounting for one third (33%) of all individuals with visual impair-
ment and more than half (51%) of blind cases worldwide [5]. Cataract is a multifactorial disease, with 
ageing being the major risk factor by far [1,3]. As people live longer, the prevalence of cataract is expect-
ed to rise correspondingly, posing challenges for health systems. From the public health perspective, un-
derstanding the magnitude of cataract and cataract blindness is the first step in prevention and treatment, 
and can provide a basis for evidence-based policy making and public health resources allocation [19]. 
Despite this, comprehensive review of data regarding the prevalence and burden of cataract on a global 
basis has never, to the best of our knowledge, been documented previously. This may largely due to the 
difficulty of combining prevalence data from different national, regional, racial and ethnic groups, espe-
cially in cases where inconsistent definitions of cataract were adopted and a universally recognized stan-
dardisation was lacking.
Similarly, in the largest developing country, China, few national-representative investigations have been 
conducted to provide precise estimates of the prevalence of cataract or cataract blindness in general Chi-
nese population. Nevertheless, a growing number of population-based studies on the epidemiology of 
cataract have been conducted across the nation during the past decades, which have reported an overall 
cataract prevalence of from less than 10% to more than 50% in various samples [20-23]. The substantial 
variations might largely come from the disparities of cataract definitions (eg, with reduced visual acuity 
or not, different cut-offs for defining reduced visual acuity), as well as the different characteristics of in-
dividual studies (eg, the age structure of the investigated population and the geographic location of the 
study sites) [21,24-26]. Until recently, no information has been compiled for the prevalence of cataract 
and cataract blindness in China, and the magnitude of the national number of people with cataract and 
cataract blindness in general Chinese population remains unclear. As Chinese population is progressive-
ly ageing, an increasing burden of cataract and cataract blindness is also expected [27-30]. If nothing else 
alters, the corresponding increased demand for cataract surgery will present new challenges for the Chi-
nese health system.
In view of uncertainties about the prevalence of cataract and cataract blindness in China, we conducted 
a comprehensive systematic review, in both Chinese and English databases, to retrieve all population-based 
studies that reported the prevalence of cataract or cataract blindness in China from 1990 onwards. By us-
ing standardized definitions of cataract and cataract blindness, we quantitatively summarised the preva-
lence of cataract and cataract blindness in China. Furthermore, the geographic patterns and secular trend 
of cataract/cataract blindness prevalence were also examined to add insights to the public health domain, 
assisting both researchers and policymakers to prioritize health care resources needed. The principal aims 
of this study were: 1) to determine the prevalence and number of people affected by cataract and cataract 
blindness at the national level from 1990 to 2015; 2) to project the prevalence and number of people with 
cataract and cataract blindness at the national level till 2050; and 3) to examine regional differences in 
the prevalence of cataract and number of affected people from 2000 to 2010.
METHODS
Systematic review
This systematic review and meta-analysis conforms to the Preferred Reporting Items for Systematic re-
views and Meta-Analyses (PRISMA) guidelines and the Guidelines for Accurate and Transparent Health 
Estimates Reporting (GATHER) statement [31,32].
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Search strategy
Three Chinese and three English bibliographic databases, including China National Knowledge Infra-
structure (CNKI), Wanfang, Chinese Biomedicine Literature Database (CBM-SinoMed), PubMed, Embase, 
and Medline, were searched using a comprehensive search strategy to identify all relevant articles on the 
prevalence of cataract or cataract blindness in general Chinese population published from January 1990 
onwards. Search terms that related to cataract (“cataract” or “cataracts”), prevalence (“incidence”, “preva-
lence”, “morbidity”, “mortality”, “epidemiology”) and China (“China”, “Chinese”, “Hong Kong”, “Macau”, 
“Taiwan”) were combined in forms of controlled vocabularies (eg, Medical Subject Heading terms) and 
free text terms. No language restrictions were placed in the search or in the selection process. The com-
plete search strategies are described in Table S1 in Online Supplementary Document, which were con-
ceived and adapted to fit features of different bibliographic databases. To supplement the database search-
es, reference lists of all included articles were also scrutinised to identify additional data sources.
Inclusion and exclusion criteria
To be included in the systematic review, studies needed to be population-based primary studies, report-
ing the prevalence of cataract or cataract blindness in Chinese population of a defined age and sex struc-
ture. Herein, the prevalence of cataract or cataract blindness should be calculated based on the number 
of affected individuals, rather than the number of affected eyes. Definitions of cataract/cataract blindness 
and measurements of visual acuity should be clearly stated. To avoid potentially biased information, we 
excluded hospital-based studies, studies that were conducted among populations of Chinese origin but 
residing outside China, and those confined to a specific population that was not representative of the gen-
eral population (people with a specific health condition, people covered by health insurance, etc.). Nar-
rative reviews, case reports, commentaries, editorials, conference proceedings and studies without prima-
ry data or explicit methodologies were additionally excluded. Furthermore, studies that reported prevalence 
rates based on self-reported data were also excluded because an underestimation was very likely. For mul-
tiple articles that reported duplicated or overlapping data of the same single study, the one with the most 
representative results or largest sample size was kept.
During the systematic review process, the definition of cataract was found to vary dramatically among 
studies (Table S2 in Online Supplementary Document): some studies defined cataract as the presence 
of lens opacities without diminished visual acuity, whereas other studies documented cataract in people 
with reduced visual acuity, which was determined by either best corrected visual acuity (BCVA) or pre-
senting visual acuity (PVA) [21,25,26,33]. The cut-offs of reduced visual acuity in different studies varied 
widely from 0.50 decimal Snellen (6/12) to 0.70 decimal Snellen (6/9) [21,26], and those for defining 
blindness ranged from 0.05 decimal Snellen (6/120) to 0.10 decimal Snellen (6/60) [25,33]. To ensure 
maximum comparability across studies and the ability to synthesize data from various studies, only stud-
ies that adopted a standardized definition of cataract or cataract blindness were eligible for the meta-anal-
ysis. Herein the standardized definitions of cataract and cataract blindness refer to the definitions that 
were most widely taken in Chinese epidemiological surveys (Table 1). In summary, cataract could be 
unilateral or bilateral, with reduced visual acuity (BCVA≤0.70), and include pseudophakia/aphakia. Cat-
aract was further categorized as any cataract (including all subtypes of cataract without further sub-clas-
sifications) or ARC (being explicitly indicated as the age-related subtype of cataract). Cataract blindness 
must be bilateral and include operated cases. Since it is generally impossible to obtain the preoperative 
visual acuity of an operated eye, if one person’s both eyes were operated on for cataract, he/she was pre-
sumed to have been bilaterally cataract blind preoperatively; or if only one eye was operated on for cata-
ract and the fellow eye was blind because of cataract at the time of examination, then this person was also 
presumed to have bilateral cataract blindness [25,34,35]. Those basic assumptions about cataract blind-
ness should be compiled into the included studies that reported the prevalence of cataract blindness. Ac-
cording to different cut-offs of visual acuity for defining 
blindness, cataract blindness was categorized as cataract 
blindness by BCVA<0.05, by BCVA<0.10 and by 
PVA<0.10 respectively.
Study selection and data extraction
All duplicate records within and between different bib-
liographic databases were identified and eliminated be-
fore conducting the formal systematic review. Two inde-
Table 1. The standardized definitions of cataract and cataract 
blindness in the systematic review
Cataract
1) Lens opacities presenting in at least one eye (unilateral or bilateral);
2) With BCVA≤0.70 in the cataract-affected eye;
3) Including pseudophakia/aphakia.
Cataract blindness
1) being blind in the better-seeing eye caused by cataract;
2) Including pseudophakia/aphakia.
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pendent reviewers (PS and HW) screened titles and abstracts of all retained records. Then the full texts 
of potentially relevant articles were retrieved and further appraised for inclusion against the eligibility 
criteria. All discrepancies were resolved through discussions until consensuses were reached.
Finally, relevant data were extracted from the eligible articles by using a pilot tested and refined extraction 
table, which included three main categories:
1)  Characteristics of the study: authors, publication year, study setting, survey year, sampling meth-
od, study design (cross-sectional or cohort), case definition and assessment method;
2)  Characteristics of the investigated population: sample size, population type (urban or rural), sex 
(male or female), and age (age range, mean or median age, or midpoint of the age range);
3)  Prevalence data: the number of people with cataract/cataract blindness and the number of partici-
pants who had been tested, by age group, sex, setting and cataract/cataract blindness subtype where 
possible.
In cases where stratified prevalence estimates were not available by sex and setting, and only the overall 
estimates were reported, sex or setting were labelled as “mixed”. Studies were grouped into six geograph-
ic regions according to their study sites. Those geographic regions included North China, Northeast Chi-
na, East China, South Central China, Southwest China and Northwest China, which were delineated by 
the National Bureau of Statistics of China (Table 2) [36-39]. If people in different geographic areas were 
examined in the same study, prevalence data were extracted for each geographic area separately, where 
available. For four studies where the years of survey were not specified, three years were subtracted from 
their publication years to impute the survey years, which was based on the average time lag from survey 
to publication in studies that provided such information. For studies that reported censoring age groups, 
eg, older than 80 years, less than 50 years, the missing age band was imputed by taking the same width 
as other age groups in the same study.
Table 2. The six geographic regions in China
Region included pRovinces
North China Beijing Municipality, Hebei province, Inner Mongolia Autonomous Region, Shanxi province, Tianjin Municipality;
Northeast China Heilongjiang province, Jilin province, Liaoning province;
East China Anhui province, Fujian province, Jiangsu province, Jiangxi province, Shandong province, Shanghai Municipality, Zhejiang province;
South Central China Guangdong province, Guangxi Zhuang Autonomous Region, Hainan province, Henan province, Hubei province, Hunan province;
Southwest China Chongqing Municipality, Guizhou province, Sichuan province, Tibet Autonomous Region, Yunnan province;
Northwest China Gansu province, Ningxia Hui Autonomous Region, Qinghai province, Shaanxi province, Xinjiang Uyghur Autonomous Region;
Statistical analysis
Epidemiological modelling of cataract prevalence and pooled prevalence of cataract blindness
Before synthesizing the abstracted data, unadjusted prevalence of cataract (any cataract and ARC) and 
cataract blindness (by BCVA<0.05, by BCVA<0.10 and by PVA<0.10) was first calculated on the basis of 
crude numerators and denominators derived from individual studies. In this study, random-effects me-
ta-analysis was performed throughout because sizeable heterogeneity of reported prevalence in different 
studies was suggested (Table S3 and Figures S1-S5 in Online Supplementary Document).
For cataract, multiple outcome measurements were available within a single study. To accommodate for 
this hierarchical data structure (clustering of different stratum-specific prevalence rates from the same 
study), a multilevel mixed-effects meta-regression model was fitted [40,41]. Before constructing models 
for estimating the prevalence of cataract, the associations of prevalence rates and study-level variables of 
interest, ie, age, sex (male and female), setting (urban, rural and mixed), geographic region and survey 
year were first explored using univariable meta-regression. This was done for any cataract and ARC sep-
arately. Age and sex were identified as variables that were commonly associated with the prevalence of 
both any cataract and ARC (Table S4 in Online Supplementary Document). For the purpose of produc-
ing the national “envelopes” (total number of cases) of any cataract and ARC, the age- and sex-specific 
prevalence estimates of any cataract and ARC were developed. Given that:
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Prevalence = p = number of cases/sample size,
Then, the prevalence rates were transformed using a logit link [42]:
logit(p) = log
e
(p/1 - p) = log
e
(odds) = α +β
1
 × x
1
 + β
2
 × x
2 
+…β
n
 × x
n
Given age and sex were the prespecified variables:
logit(p) = α + β
1
 × (age) + β
2
 × (sex)
Thus, the prevalence of any cataract/ARC was:
P = eα+β1 × (age) + β2 × (sex)/1 + eα+β1 × (age) + β2 × (sex)
For cataract blindness, the stratum-specific prevalence rates were not universally available in the includ-
ed studies. Therefore, the pooled prevalence, with 95% confidence intervals (CIs), was obtained from a 
random-effects meta-analysis model (DerSimonian and Laird method) with inverse-variance weighting. 
The variance of prevalence was also stabilised with the logit transformation [42]. To check whether a sin-
gle study disproportionally influenced the pooled results, the sensitivity analysis was conducted by re-
moving one study at a time to run the meta-analysis without it [43]. We also assessed the publication bias 
by visual inspection of funnel plots test [44].
Estimation of the national number of people with cataract and cataract blindness  
from 1990 to 2015
The total number of people affected by cataract (“cataract envelope”, including post-surgical cases) in 
China was generated by applying the modelled age- and sex-specific prevalence for each 5-year age group 
to the corresponding population subgroup in China, available from the United Nations Population Divi-
sion (UNPD) [45]. This was performed for any cataract and ARC respectively in the years 1990, 2000, 
2010 and 2015.
For cataract blindness, the age- and sex-specific prevalence estimates were not specifically constructed, 
the overall number of people affected by cataract blindness (including post-surgical cases) was, therefore, 
estimated by multiplying the pooled prevalence of cataract blindness by the national population. This 
was conducted for the three subgroups of cataract blindness determined by different definitions of blind-
ness (by BCVA<0.05, by BCVA<0.10 and by PVA<0.10) from 1990 to 2015.
Projection of the national number of people with cataract and cataract blindness  
from 2020 to 2050
To derive the projected number of people with cataract/cataract blindness (including post-surgical cases) 
for the period 2020-2050, the age- and sex-specific prevalence of cataract and the pooled prevalence of 
cataract blindness were assumed to stay constant over time. For cataract, this assumption was supported 
by the univariable meta-regression models, where no significant association between survey year and the 
prevalence of cataract (both any cataract and ARC) was detected (Table S4 in Online Supplementary 
Document). The national number of people living with cataract and cataract blindness from 2020 to 2050 
was projected by following the same approach as used for deriving the national number of cataract and 
cataract blindness cases from 1990 to 2015. The demographic projection was taken from the UNPD me-
dium variant population scenario, which was underpinned by assumptions about future fertility and mor-
tality [45,46].
Effects of demographic and geographic factors on the prevalence of cataract
Where appropriate (at least seven contributing estimates should be available for each variable [47]), the 
effects of demographic (ie, age, sex) and geographic features (ie, setting, geographic region) on the prev-
alence of cataract were initially assessed by univariable meta-regression models. The effect of survey year 
on the prevalence of cataract was also explored by introducing the survey year into the models. Finally, 
all variables with p values of less than 0.1 in univariable meta-regression models were entered into the 
multivariable meta-regression.
Estimation of the subnational number of people with cataract from 2000 to 2010
To generate the number of people with cataract in the six geographic regions, an “envelope” approach 
was adopted. This “envelope” approach was previously endorsed by the Child Health Epidemiology Ref-
erence Group (CHERG), and has, since, been widely advocated in the disease burden domain [38,39,48-
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51]. First, based on the final multivariable meta-regression that took the effects of demographic and geo-
graphic features into account, cataract prevalence in each geographic region was calculated respectively. 
Then the regional cases of cataract were estimated by multiplying the regional cataract prevalence by their 
corresponding population. Finally, the regional cataract cases were adjusted to fit into the national “cata-
ract envelope”. This was done for the years 2000 and 2010, where the regional population data could be 
derived from the fifth and sixth censuses respectively [36,37].
All statistical analyses were done with R, version 3.3.0 (R Foundation for Statistical Computing, Vienna, 
Austria) with the packages meta (version 4.8-4), metaphor (version 2.0-2) and ggplot2 (version 2.2.1) 
[52]. A two-sided p-value of less than 0.05 was regarded as indicative of statistically significant, unless 
otherwise specified. All maps were created using ArcMap version 10.1 (Environmental Systems Research 
Institute, Redlands, CA, USA), based on the China base map (in shapefile format) obtained from the Glob-
al Administrative Areas (GADM) database (GADM, 2015, version 2.0; www.gadm.org).
RESULTS
Summary of systematic review
The initial literature search yielded a total of 
16345 citations. After removing 8181 dupli-
cates, the titles and abstracts of 8164 unique 
records were screened for relevance. Of these, 
1414 potentially relevant articles were reviewed 
in full-text form and 1359 were subsequently 
excluded. Finally, 55 studies met the eligibility 
criteria and were included in the systematic re-
view and meta-analysis. The review process is 
summarized in Figure 1 as a PRISMA flow-
chart. A list of the included studies is available 
in Table S5 in Online Supplementary Docu-
ment.
Table 3 summarises the main characteristics of 
the 55 included studies. All those studies were 
cross-sectional in design, among which the ma-
jority were published in this decade (from 2010 
onwards). Most studies were relatively large, 
with more than 2000 participants. Almost all 
studies provided sex-specific data, enabling the 
exploration of sex difference in cataract preva-
lence. Of the included studies, 35 studies ex-
amined the prevalence of any cataract, ten pro-
vided prevalence data on ARC; eight studies 
focused on the prevalence of cataract blindness 
by BCVA<0.05, nine on the prevalence of cata-
ract blindness by BCVA<0.10, and 12 on the 
prevalence of cataract blindness by PVA<0.10. 
The diverse geographical areas covered by the included studies are shown in Figure 2, and the detailed 
characteristics of all included studies are demonstrated in Table S6 in Online Supplementary Document.
Age- and sex-specific prevalence of cataract and pooled prevalence  
of cataract blindness
For cataract, a substantial number of data points from the included studies guaranteed our ability to con-
struct the relation between age and prevalence (Figure 3). The age range covered by informative data points 
for any cataract was wider than that for ARC. To ensure the comparability of the estimated prevalence of 
any cataract and ARC, the age range in this study was set as from 45 to 89 years, where the most informa-
tive data points concentrated. The effect of sex on the prevalence of cataract was also assessed based on 
studies that provided sex-specific cataract prevalence (Table S4 in Online Supplementary Document).
Figure 1. Systematic review flow diagram of studies on cataract and cataract 
blindness prevalence in China. *Reason 1 – Studies that were conducted in a 
population with unrepresentative characteristics (hypertensive patients, 
people with reduced vision, etc.); *Reason 2 – Studies that were not 
population-based; *Reason 3 – Studies that relied on self-reported diagnoses 
of cataract or cataract blindness; *Reason 4 – Papers with no numerical 
prevalence measure of cataract or cataract blindness; *Reason 5 – Studies 
that didn’t adopt the standardized definitions of cataract and cataract 
blindness; *Reason 6 – M ultiple publications of the same study; *Reason 7 
– Studies that were not based in China.
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Table 3. Main characteristics of the included studies on cataract and cataract blindness in China (n = 55)
chaRacteRistics
numbeR of studies pRovided pRevalence data on (%)*
Any cataract 
(n = 35)
ARC (n = 10)
Cataract 
blindness by 
BCVA<0.05 (n = 8)
Cataract 
blindness by 
BCVA<0.10 (n = 9)
Cataract 
blindness by 
PVA<0.10 (n = 12)
Year published:
1990-1999 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (8.3)
2000-2009 10 (28.6) 6 (60.0) 4 (50.0) 0 (0.0) 4 (33.3)
2010-2017 25 (71.4) 4 (40.0) 4 (50.0) 9 (100.0) 7 (58.3)
Setting:
Urban 11 (31.4) 3 (30.0) 3 (37.5) 0 (0.0) 4 (33.3)
Rural 12 (34.3) 4 (40.0) 3 (37.5) 5 (55.6) 5 (41.7)
Mixed 10 (28.6) 2 (20.0) 1 (12.5) 4 (44.4) 2 (16.7)
Both 2 (5.7) 1 (10.0) 1 (12.5) 0 (0.0) 1 (8.3)
Sex:
Mixed 4 (11.4) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Both 31 (88.6) 10 (100.0) 8 (100.0) 9 (100.0) 12 (100.0)
Sample size:
≤2000 7 (20.0) 4 (40.0) 1 (12.5) 1 (11.1) 1 (8.3)
2001-5000 11 (31.4) 2 (20.0) 5 (62.5) 1 (11.1) 6 (50.0)
5001–10000 12 (34.3) 3 (30.0) 2 (25.0) 5 (55.6) 4 (33.3)
>10000 5 (14.3) 1 (10.0) 0 (0.0) 2 (22.2) 1 (8.3)
Geographic region†:
North China 6 (17.1) 3 (20.0) 2 (25.0) 2 (15.4) 2 (16.7)
Northeast China 2 (5.7) 1 (6.7) 1 (12.5) 1 (7.7) 0 (0.0)
East China 15 (42.9) 3 (20.0) 2 (25.0) 7 (53.8) 4 (33.3)
South Central China 4 (11.4) 2 (13.3) 0 (0.0) 1 (7.7) 1 (8.3)
Southwest China 3 (8.6) 2 (13.3) 2 (25.0) 1 (7.7) 5 (41.7)
Northwest China 5 (14.3) 4 (26.7) 1 (12.5) 1 (7.7) 0 (0.0)
*Some studies reported the prevalence estimates of any cataract, ARC, cataract blindness by BCVA<0.05, cataract blindness by 
BCVA<0.10 and cataract blindness by PVA<0.10 simultaneously, therefore the sum of the number of studies exceeded 55.
†Some studies covered more than one geographic region, therefore the sum of coved geographic regions exceeded the sum of studies.
Figure 2. Geographical distribution of the included studies on cataract and cataract  
blindness prevalence in China (n = 55).
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Table 4 and Figure 4 demonstrate the estimated 
age- and sex-specific prevalence of any cataract and 
ARC. Generally, the prevalence of any cataract and 
ARC was higher in females than in males, and both 
showed a steady rise with advanced age. In males, 
the prevalence of any cataract ranged from 6.71% 
(95% CI = 5.06-8.83) in people aged 45-49 years to 
73.01% (95% CI = 65.78-79.2) in elderly aged 85-
89 years. In females, the prevalence of any cataract 
increased from 8.39% (95% CI = 6.36-10.98) in in-
dividuals aged 45-49 years to 77.51% (95% 
CI = 71.00-82.90) in those aged 85-89 years. In the 
case of ARC, the prevalence rates ranged from 
3.23% (95% CI = 1.51-6.80) in males aged 45-49 
years to 65.78% (95% CI = 46.72-80.82) in those 
aged 85-89 years. The prevalence of ARC in females 
was consistently higher than that in males, ranging 
from 4.72% (95% CI = 2.22-9.76) in the 45-49 years 
age group to 74.03% (95% CI = 56.53-86.21) in the 
85–89 years age group.
Figure 3. Age-specific prevalence of cataract and ARC based on informative data points from the included studies. Note: The size of 
each bubble is proportional to the sample size. For cataract, there were 143 data points for constructing the relation between age and 
prevalence; For ARC, there were 66.
Table 4. Estimated sex-specific prevalence of any cataract and ARC in 
China, by age group
age 
(yeaRs)
pRevalence of any cataRact (%, 95% ci) pRevalence of aRc (%, 95% ci)
Male Female Male Female
45-49
6.71 8.39 3.23 4.72
(5.06-8.83) (6.36-10.98) (1.51-6.80) (2.22-9.76)
50-54
10.16 12.59 5.25 7.59
(7.91-12.97) (9.86-15.95) (2.48-10.76) (3.64-15.17)
55-59
15.11 18.49 8.42 12.00
(12.06-18.77) (14.88-22.73) (4.07-16.64) (5.91-22.84)
60-64
21.89 26.30 13.24 18.46
(17.86-26.53) (21.69-31.50) (6.58-24.87) (9.46-32.92)
65-69
30.60 35.97 20.22 27.31
(25.45-36.29) (30.31-42.05) (10.47-35.45) (14.78-44.88)
70-74
40.97 46.92 29.60 38.41
(34.69-47.55) (40.36-53.59) (16.23-47.71) (22.33-57.50)
75-79
52.20 58.18 41.10 50.86
(45.07-59.25) (51.10-64.94) (24.30-60.28) (32.25-69.24)
80–84
63.22 68.65 53.67 63.21
(55.73-70.12) (61.59-74.93) (34.67-71.65) (44.05-78.94)
85-89
73.01 77.51 65.78 74.03
(65.78-79.20) (71.00-82.90) (46.72-80.82) (56.53-86.21)
Figure 4. Estimated 
age- and sex-specific 
prevalence of any 
cataract and ARC in 
China, with 95% 
confidence intervals.
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For cataract blindness, the pooled prevalence estimates 
by random-effects meta-analyses are shown in Figure 5. 
Overall, the pooled prevalence of cataract blindness by 
BCVA<0.05 was 2.30% (95% CI = 1.72-3.07) and that of 
cataract blindness by BCVA<0.10 was 2.56% (95% 
CI = 1.94-3.38). At a more relaxed threshold level for de-
fining blindness, the pooled prevalence of cataract blind-
ness by PVA<0.10 was 4.51% (95% CI = 3.53-5.75). Ac-
cording to the leave-one-out sensitivity analysis, no single 
study had a substantial influence on the overall preva-
lence of cataract blindness, where the pooled prevalence 
of cataract blindness by BCVA<0.05 ranged from 2.11% 
(95% CI = 1.59-2.81) to 2.45% (95% CI = 1.82-3.30), that 
of cataract blindness by BCVA<0.10 from 2.38% (95% 
CI = 1.98-2.87) to 2.67% (95% CI = 2.00-3.55), and that 
of cataract blindness by PVA<0.10 from 4.28% (95% 
CI = 3.32-5.49) to 4.81% (95% CI = 3.81-6.06) (Figure S6 
in Online Supplementary Document). The asymmetri-
cal shape of funnel plots revealed some evidence of po-
tential publication bias (Figure S7 in Online Supplemen-
tary Document).
National number of people with cataract 
and cataract blindness  
from 1990 to 2015
For cataract, the numbers of people with any cataract and 
ARC were computed by applying the age- and sex-specif-
ic prevalence rates to the correspondingly stratified na-
tional population aged 45-89 years in the years 1990, 
2000, 2010 and 2015 (Table 5 and Table S7 in Online 
Supplementary Document. At the national level, the 
prevalence of any cataract in people aged 45-89 years 
slightly decreased by 1.13%, from 22.21% (95% 
CI = 18.46-26.42) in 1990 to 21.96% (95% CI = 18.26-
26.10) in 2015. During this period, the prevalence of ARC in people 45-89 years of age ranged from 
15.65% (95% CI = 8.67-26.06) to 15.53% (95% CI = 8.67-25.71), indicating an overall decreasing rate of 
0.79%. Despite the gentle decline in prevalence estimates within this time frame, there was a consider-
able increase in the national number of people with cataract. In people aged 45-89 years, the number of 
any cataract cases was 50.75 million (95% CI = 42.17-60.37) in 1990 and 111.74 million (95% CI = 92.94-
132.84) in 2015, and that of ARC cases rose from 35.77 million (95% CI = 19.81-59.55) in 1990 to 79.04 
million (95% CI = 44.14-130.85) in 2015, which yielded overall increasing rates of 120.19% and of 
Figure 5. Forest plots of cataract blindness prevalence in China. 
Note: Data were pooled by a random-effects model; the size of the 
blue shaded areas is proportional to the weight of each study.
Table 5. Estimated prevalence and number of people with cataract and cataract blindness in China from 1990 to 2015
type
pRevalence (%, 95% ci) numbeR of people with disease  
(million, 95% ci)
Relative Rate of change  
(%, 1990-2015)
1990 2015 1990 2015 Prevalence Cases
Cataract
22.21 21.96 50.75 111.74
-1.13 +120.19
(18.46-26.42) (18.26-26.10) (42.17-60.37) (92.94-132.84)
ARC
15.65 15.53 35.77 79.04
-0.79 +120.96
(8.67-26.06) (8.67-25.71) (19.81-59.55) (44.14-130.85)
Cataract blindness (BCVA<0.05)
2.30 5.26 11.71
–
+122.72
(1.72-3.07) (3.93-7.02) (8.75-15.62)
Cataract blindness (BCVA<0.10)
2.56 5.85 13.03
–
(1.94-3.38) (4.43-7.72) (9.87-17.20)
Cataract blindness (PVA<0.10)
4.51 10.31 22.95
–
(3.53-5.75) (8.07-13.14) (17.97-29.26)
V
IE
W
PO
IN
TS
Song et al.
RE
SE
A
RC
H
 T
H
E
M
E
 4
:  
H
E
A
LT
H
 T
RA
N
SI
TI
O
N
S 
IN
 C
H
IN
A
JUne  2018  •  Vol. 8 No. 1 •  010804 10 www.jogh.org •  doi: 10.7189/jogh.08.010804
120.96% respectively throughout this period. In 2015, around 71% of the cataract cases were the age-re-
lated subtype, and the age group that contributed the most cases was 60-64 years for both any cataract 
and ARC (Figure 6).
For cataract blindness, the overall prevalence was assumed to be constant over the period 1990-2015, 
but even so, an increasing trend in cataract-blind cases was witnessed (Table 5). From 1990 to 2015, the 
number of people with cataract blindness by BCVA<0.05 (aged 45-89 years) increased from 5.26 million 
(95% CI = 3.93-7.02) to 11.71 million (95% CI = 8.75-15.62), and those with cataract by BCVA<0.10 rose 
from 5.85 million (95% CI = 4.43-7.72) to 13.03 million (95% CI = 9.87-17.20). By using the cut-off of 
PVA<0.10 for defining blindness, the number of people with cataract blindness (aged 45-89 years) ranged 
from 10.31 million (95% CI = 8.07-13.14) to 22.95 million (95% CI = 17.97-29.26) within the same time 
frame.
Figure 6. Estimated sex-specific number of people with any cataract and ARC in China from 
1990 to 2015, with contributing age groups.
Projection of national number of people with cataract and cataract blindness 
from 2020 to 2050
For cataract, the projection of national affected cases from 2020 to 2050 was based on the assumption 
that the age- and sex-specific prevalence of any cataract and ARC would remain constant over time. By 
extrapolating the estimated age- and sex-specific prevalence of any cataract and ARC to the UNPD data, 
the numbers of people with any cataract and ARC were projected up to the year 2050 (Table 6 and Table 
S7 in Online Supplementary Document). Given the demographic changes over the next three decades, 
the prevalence of any cataract in people aged 45-89 years is expected to increase from 22.78% (95% 
CI = 18.98-27.03) to 33.34% (95% CI = 28.53-38.40), and that of ARC from 16.21% (95% CI = 9.07-
26.72) to 25.93% (95% CI = 15.67-38.94) between the years 2020 and 2050, which will indicate increas-
ing rates of 46% and 60% respectively. In people aged 45-89 years, the total number of affected cases is 
projected to keep increasing, with the number of those with ARC at a higher rate than those with any 
cataract (100% vs 83%). In 2020, the total number of people with any cataract (aged 45-89 years) will 
be 131.92 million (95% CI = 109.91-156.49), and this figure is projected to increase to 240.83 million 
(95% CI = 206.07-277.35) by the year 2050. Among them, the number of people with ARC is projected 
to grow relatively rapidly from 93.83 million (95% CI = 52.52-154.69) in 2020 to 187.26 million (95% 
CI = 113.17-281.23) in 2050. By then, ARC will account for 78% of all cataract cases in China, and the 
age group where most cases concentrate will be 75-79 years for any cataract and 80-84 years for ARC 
(Figure 7).
For cataract blindness (Table 6), the number of people with cataract blindness by BCVA<0.05 (aged 45-
89 years) is projected to rise from 13.32 million (95% CI = 9.96-17.78) in 2020 to 16.61 million (95% 
CI = 12.42-22.17) in 2050, while those with cataract by BCVA<0.10 (aged 45-89 years) from 14.82 mil-
lion (95% CI = 11.23-19.57) to 18.49 million (95% CI = 14.01-24.41) during this period. When applying 
V
IE
W
PO
IN
TS
National and subnational prevalence of cataract and cataract blindness in China
RE
SE
A
RC
H
 T
H
E
M
E
 4
:  
H
E
A
LT
H
 T
RA
N
SI
TI
O
N
S 
IN
 C
H
IN
A
www.jogh.org •  doi: 10.7189/jogh.08.010804 11 June  2018  •  Vol. 8 No. 1 •  010804
a less stringent cut-off of PVA<0.10 for blindness, the number of people with cataract blindness (aged 
45-89 years) is expected to grow from 26.11 million (95% CI = 20.44-33.29) in 2020 to 32.58 million 
(95% CI = 25.50-41.53) in 2050.
Effects of demographic and geographic factors on the prevalence of cataract
Results from the univariable meta-regression analyses revealed that age and sex were significantly associ-
ated with the prevalence of both any cataract and ARC, with older people and females having higher prev-
alence rates. No secular trend or urban-rural difference in the prevalence of any cataract or ARC were re-
vealed (Table S4 in Online Supplementary Document). In addition, a weaker association was seen for 
the geographic distribution of any cataract prevalence, where people living in North China were suggest-
ed to be with a relatively lower prevalence than those in East China (P < 0.1). For the purpose of con-
structing a multivariable regression model, insufficient data were available for ARC. Therefore, a multi-
variable regression model that took the effects of age, sex and geographic region simultaneously was only 
developed for any cataract:
logit(p) = –6.740 + 0.091 × Age+(–0.242) × Gender
male
+U
region
Where p indicates the prevalence of any cataract; Age refers to the absolute value of age, Gender
male
 = 1 for 
males and = 0 for females; U
region
 represents the region-level effect, which equals to 0 for East China, -0.269 
for North China, 0.486 for Northeast China, -0.075 for Northwest China, 0.636 for South Central China 
and 0.125 for Southwest China.
Table 6. Projected prevalence and number of people with cataract and cataract blindness in China from 2020 to 2050
type
pRevalence (%, 95% ci) numbeR of people with disease  
(million, 95% ci)
Relative Rate of change  
(%, 2020-2050)
2020 2050 2020 2050 Prevalence Cases
Cataract
22.78 33.34 131.92 240.83
+46.35 +82.56
(18.98-27.03) (28.53-38.40) (109.91-156.49) (206.07-277.35)
ARC
16.21 25.93 93.83 187.26
+59.98 +99.57
(9.07-26.72) (15.67-38.94) (52.52-154.69) (113.17-281.23)
Cataract blindness (BCVA<0.05)
2.30 13.32 16.61
–
+24.75
(1.72-3.07) (9.96-17.78) (12.42-22.17)
Cataract blindness (BCVA<0.10)
2.56 14.82 18.49
–
(1.94-3.38) (11.23-19.57) (14.01-24.41)
Cataract blindness (PVA<0.10)
4.51 26.11 32.58
–
(3.53-5.75) (20.44-33.29) (25.50-41.53)
Figure 7. Projected sex-specific number of people with any cataract and ARC in China from 
2020 to 2050, with contributing age groups.
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Regional number of people with any cataract from 2000 to 2010
Based on the final formula for developing the age- and sex-specific prevalence of any cataract in different 
regions, the national cases of any cataract in the years 2000 and 2010 were respectively allocated into the 
six geographic regions in China (Table 7). In 2000, the prevalence of any cataract in people aged 45-89 
years was 21.62% (95% CI = 17.97-25.72) in China, varying from 15.05% (95% CI = 11.39-19.43) in 
North China to 28.38% (95% CI = 23.80-32.92) in South Central China. In 2010, the national prevalence 
of any cataract in people aged 45-89 years rose to 21.96% (95% CI = 18.26-26.11). The region with the 
highest prevalence of any cataract was still South Central China (28.50% [95% CI = 23.91-33.07]) and 
that with the lowest prevalence of any cataract was still North China (15.03% [95% CI = 11.39-19.43]). 
During 2000-2010, the prevalence of any cataract slightly increased by 1.57%, with the most pronounced 
increase occurring in Southwest China (7.31%). Northeast China was the only region with a declining 
rate in the prevalence of any cataract (0.11%) during this period.
As demonstrated in Table 7 and Figure 8, a total of 68.33 million (95% CI = 56.79-81.29) people aged 
45-89 years were affected by any cataract in 2000. Among them, more than one-third (34%) were living 
in South Central China (23.50 million, 95% CI = 19.70-27.26) and only 5% were in Northwest China 
(3.37 million, 95% CI = 2.58-4.31). With the demographic ageing trend in China, the national number 
Figure 8. Estimated regional number of people with any cataract and contributing age 
groups in the years 2000 and 2010.
Table 7. Estimated prevalence and number of people with any cataract in China from 2000 to 2010, by geographic 
region
Region
pRevalence of any cataRact (%, 95% ci) numbeR of people with any cataRact  (million, 95% ci)
Relative Rate of change  
(%, 2000-2010)
2000 2010 2000 2010 Prevalence Cases
North China
15.05 15.03 5.62 8.13
-0.11 +44.53
(11.39-19.43) (11.39-19.43) (4.26-7.26) (6.16-10.50)
Northeast China
24.14 24.57 6.80 10.30
+1.77 +51.34
(15.86-33.25) (16.20-33.80) (4.47-9.37) (6.79-14.16)
East China
19.36 19.53 18.89 25.72
+0.88 +36.17
(18.85-20.32) (19.05-20.49) (18.39-19.83) (25.09-26.98)
South Central China
28.38 28.50 23.50 31.79
+0.41 +35.25
(23.80-32.92) (23.91-33.07) (19.70-27.26) (26.67-36.88)
Southwest China
20.24 21.72 10.14 13.28
+7.31 +30.94
(14.75-26.47) (16.01-28.02) (7.39-13.26) (9.79-17.13)
Northwest China
16.83 17.33 3.37 4.87
+3.00 +44.30
(12.88-21.51) (13.34-22.01) (2.58-4.31) (3.75-6.18)
China
21.62 21.96 68.33 94.07
+1.57 +37.67
(17.97-25.72) (18.26-26.11) (56.79-81.29) (78.24-111.84)
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of people (aged 45-89 years) with any cataract reached to 94.07 million (95% CI = 78.24-111.84) by 
2010. At the regional level, the number of people with any cataract was still the largest in South Central 
China (31.79 million, 95% CI = 26.67-36.88) and the smallest in Northwest China (4.87 million, 95% 
CI = 3.75-6.18)-equivalent to 34% and 5% of the national cases of any cataract in 2010 respectively. Over 
the decade from 2000 to 2010, the number of people with any cataract increased by 38% at the national 
level. For the six geographic regions, the most marked increase was seen in Northeast China (51%) and 
the least in Southwest China (31%).
DISCUSSION
By using all published evidence on the prevalence of cataract and cataract blindness in general Chinese 
population, this systematic review and meta-analysis, for the first time, provides the most comprehensive 
figures for the prevalence of cataract and cataract blindness in China at both the national and subnation-
al levels. The data-driven estimates show that the number of people affected by cataract and cataract 
blindness in China is dramatic. From 1990 to 2015, more than one in five (around 22%) people aged 
45-89 years were affected by any cataract, representing a total of 50.75 million and 111.74 million cases 
in the years 1990 and 2015 respectively. Among them, around 71% were with the age-related subtype of 
cataract. For cataract blindness, the pooled prevalence varied substantially according to different cutoffs 
for defining blindness, from 2.30% for cataract blindness by BCVA<0.05 to 4.51% for cataract blindness 
by PVA<0.10. As the Chinese population ages, the prevalence of cataract and the number of affected peo-
ple will correspondingly increase in years to come. By the year 2050, the national cases of any cataract in 
people aged 45-89 years are projected to more than double to 240.83 million, giving a prevalence of one-
third (33.34%). At that time, ARC will account for 78% of all cataract cases in China. Moreover, substan-
tial geographic variations were also highlighted in the prevalence of any cataract, which was the highest 
in South Central China and the lowest in North China during 2000-2010. Meanwhile, in terms of the 
number of people affected by any cataract, the largest share of cases was in South Central China, while 
the smallest in Northwest China.
This systematic review and meta-analysis provides the first and most complete description of the preva-
lence of cataract and cataract blindness in China, which can be used as the basis for the formulation of 
public-health strategies to ease the burden of cataract and cataract blindness. The strengths of this study 
include comprehensive and reproducible search strategies incorporated both Chinese and English data-
bases, a dual review process and rigorous selection criteria, which reduced the potential for information 
bias due to selection and methodological heterogeneity to a minimum. During the systematic review pro-
cess, only studies that were conducted in general Chinese population were included, thus the generaliz-
ability of the whole results presented in this study was largely ensured. With an aim of enhancing the 
comparability of prevalence estimates from different individual studies, standardized definitions of cata-
ract and cataract blindness based on the available evidence were specified, which made the quantitative 
synthesis of prevalence rates possible. Moreover, the included studies that reported the prevalence of any 
cataract were sufficient and with a large geographical diversity, guaranteeing our ability to synthesize the 
prevalence of any cataract at the subnational level in China.
However, our study is still subject to several potential limitations. First, despite our extensive efforts on 
minimizing variations by means of strict eligibility criteria and unified definitions, meta-analyses of ob-
servational studies are generally vulnerable to bias and confounders inherent in the component studies 
[53]. Second, in this study, the prevalence of cataract was estimated based on multilevel mixed-effects 
meta-regression models, by taking the effects of both demographic and geographic features into account. 
However, the examined demographic and geographic features were cluster-level data, any differences in 
effects at the individual level might be hidden. Other potential risk factors for cataract, such as econom-
ic status, smoking and diabetes, could not be included in the models owing to the absence of relevant 
information. As a further limitation, the prevalence of cataract could only be estimated at the regional 
level at best, adequate estimates at the provincial level were not attainable because insufficient studies 
were from each province in China. For cataract blindness, the roughly pooled estimates of prevalence 
were based on scant epidemiological evidence, and the limited availability of data points restricted fur-
ther exploration of heterogeneity and bias by sub-group meta-analysis or meta-regression, therefore sev-
eral key differences pertinent to variations in risk factors, such as age and sex, might have been obscured. 
In terms of the cataract blindness prevalence, the assumption that all cataract-operated eyes were blind 
preoperatively might lead to an overestimation. Third, although the standardized definitions of cataract 
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and cataract blindness served as a basis for our meta-analysis, on the other hand, cataract was not defined 
primarily based on any specific grading systems of cataract, but rather according to lens opacity in con-
junction with reduced visual acuity. This approach, however, does not accord with modern grading sys-
tems, such as the Lens Opacities Classification System (LOCS), the Wisconsin Cataract Grading System 
(WCGS) and the Age-Related Eye Disease Study (AREDS) system, consequently the comparison of the 
estimates in this study with studies in other western countries would be difficult [54-60]. Of particular 
note, the cataract/cataract blindness cases referred to people who were suffering from cataract/cataract 
blindness and those who had already been operated. The currently prevalent cases of cataract/cataract 
blindness were not able to be estimated with our research approach. Therefore, the national and subna-
tional prevalence of cataract and cataract blindness presented in this study could only be compared with 
studies (both domestic and international) that adopted similar definitions of cataract and cataract blind-
ness, hindering the generalization of our results to some extent. Fourth, in the projection analysis, the 
prevalence of cataract and cataract blindness was assumed to remain constant over time. In fact, any 
changes of risk exposure in the future might increase or decrease the incidence of cataract, and imple-
mentation of preventive care might substantially delay the onset of cataract or cataract blindness. The rise 
of prevalence and number of affected people as indicated in this study mainly relied on the UNPD demo-
graphic statistics, and therefore could be argued to be a reflection of population ageing. With the above 
limitations in mind, several findings in this study should be interpreted with considerable caution.
In a synthesized analysis for estimating the prevalence of cataract in the United States (US), it was esti-
mated that 20.5 million (17.2%) Americans older than 40 years had cataract in either eye in 2000, in-
cluding those who had pseudophakia/aphakia [55]. In this study, a higher cataract prevalence of 22% was 
observed in Chinese people aged 45-89 years, corresponding to 68 million people living with cataract in 
the year 2000. The higher prevalence of cataract in China compared with that in Americans seems to 
stand by previous statements that cataract is more prevalent in Asians than in Western populations 
[3,61,62]. When compared with studies using comparable measurements of cataract blindness, the prev-
alence of cataract blindness by PVA<0.10 was noted to be slightly higher in China (4.5%) than in Nepal 
(4.1%) [34]. Given the large population size in China, this prevalence rate of cataract blindness actually 
represents a large group of people who need surgery (if they have not received) and extensive care from 
both household and community [4,63].
As revealed in our study and many previous studies, the prevalence of any cataract and ARC grows dra-
matically with advanced age and reaches the highest in older people. The prominent role of ageing as a 
cause of cataract has also been reinforced in this study, with increased age being the constant risk factor 
for both any cataract and ARC [1,3,61,64-66]. After age-adjustment, females were found to exhibit a 
greater tendency to develop cataract and ARC than males, which accords with a large body of evidence 
across racial groups [3,61,65,66]. Although the mechanism behind sex disparity in cataract formation 
has not been fully clarified, the protective effect of hormone therapy in cataract development as suggest-
ed in previous studies offers a clue for future research [1,67,68]. Taken the effects of ageing population 
and women’s greater longevity together, the numbers of people living with any cataract and ARC in Chi-
na will both more than double from 2015 to 2050 based on our projection analysis. Cataract, therefore, 
will continue to be a leading public health concern and pose wide-ranging effects on its social, econom-
ic and health systems.
In view of the geographic patterns of cataract in China, the variations in the prevalence of cataract in dif-
ferent geographic regions could be speculated as a combined result of different distributions of risk fac-
tors across the whole country. It has long been suggested that cataractogenesis is a multifactorial process, 
where individual factors, environmental factors and genetic factors all play a role [1,3]. Risk factors with 
robust evidence on cataract mainly include advanced age, female sex, smoking, excessive UV B (UVB) 
exposure, diabetes, etc. [1,3,69-71]. As revealed by our analysis, the geographic region with the highest 
prevalence of cataract was South Central China in the years of 2000 and 2010. A possible reason is the 
relatively lower latitude (as a surrogate for a higher UVB exposure level) in south China, but it is still not 
absolutely clear whether any other factors have contributed to this because relevant information was not 
universally examined in included studies.
With rapidly ageing populations in China, the question of how best to care for older people with func-
tional impairment is an ever-present concern [4,29,63]. The large cases of cataract and cataract blindness, 
and the uneven distribution across the nation, suggest that efforts to ameliorate the current and future 
burden of cataract are urgently needed. In China, the cataract surgical rate (cataract operations per mil-
lion population per year) has been reported to be 446 in 2004, which was almost the lowest among Asian 
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countries [63,72,73]. This might be resulted by the shortage of qualified eye care practitioners and health 
resources, in the meanwhile, the uncertain prognosis might also hider affected people to approach such 
operations [63,74,75]. The estimates presented in this study should be interpreted with the most recent 
cataract surgical rate in China (if available) to better inform policymakers and health care providers for 
adequate preparation for the increasing burden of cataract.
Our data also have important implications for adding new evidence into research. In the past decades, 
despite the advance in diagnostic and surgical techniques, uncertainties and discrepancy in the definitions 
and assessments of cataract still largely remain in epidemiological studies [1,3]. Until improved large-scale 
data using comparable definitions and assessments of cataract become available, the systematic review 
and meta-analysis approach will still be an important option for providing inputs by synthesizing avail-
able evidence. This is also the case in China, where improvement in the quality of population-level infor-
mation on the prevalence of cataract should be a priority for the national statistical agency, notably de-
tailed age categories, classification of different subtypes of cataract, international grading systems, should 
be adopted as are often the cases. With the emergence of high-quality epidemiological studies on cataract 
in the foreseen future, reliable prevalence estimates of cataract, and its subtypes could be well achieved. 
Further, although no confirmed methods to prevent cataract formation are being advocated, well-estab-
lished risk and protective factors demonstrate possible pathways for slowing cataract progression, such 
as smoking cessation, wearing hats and sunglasses [1,3]. Given the impact of cataract, the need for fur-
ther research on preventing and delaying disease is still highlighted.
CONCLUSIONS
In conclusion, the first and most comprehensive estimates of the prevalence of cataract and cataract blind-
ness in China were provided in this study, at both the national and subnational levels. The prevalence of 
cataract varied considerably among different demographic and geographic groups. In the coming decades, 
cataract and cataract blindness will continue to be a leading public-health issue in China. Future work 
should be prioritized on the promotion of high-quality epidemiological studies on cataract.
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